101 related articles for article (PubMed ID: 14688198)
1. Short telomeres protect from diet-induced atherosclerosis in apolipoprotein E-null mice.
Poch E; Carbonell P; Franco S; Díez-Juan A; Blasco MA; Andrés V
FASEB J; 2004 Feb; 18(2):418-20. PubMed ID: 14688198
[TBL] [Abstract][Full Text] [Related]
2. The growth suppressor p27(Kip1) protects against diet-induced atherosclerosis.
Díez-Juan A; Andrés V
FASEB J; 2001 Sep; 15(11):1989-95. PubMed ID: 11532979
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
4. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing.
Wong KK; Maser RS; Bachoo RM; Menon J; Carrasco DR; Gu Y; Alt FW; DePinho RA
Nature; 2003 Feb; 421(6923):643-8. PubMed ID: 12540856
[TBL] [Abstract][Full Text] [Related]
5. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
6. Genetic ablation of caveolin-1 confers protection against atherosclerosis.
Frank PG; Lee H; Park DS; Tandon NN; Scherer PE; Lisanti MP
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):98-105. PubMed ID: 14563650
[TBL] [Abstract][Full Text] [Related]
7. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
8. Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.
Merched AJ; Chan L
Circulation; 2004 Dec; 110(25):3830-41. PubMed ID: 15596565
[TBL] [Abstract][Full Text] [Related]
9. Mouse models of experimental atherosclerosis.
Jawień J; Nastałek P; Korbut R
J Physiol Pharmacol; 2004 Sep; 55(3):503-17. PubMed ID: 15381823
[TBL] [Abstract][Full Text] [Related]
10. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
11. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
[TBL] [Abstract][Full Text] [Related]
12. Telomerase RNA levels limit the telomere length equilibrium.
Greider CW
Cold Spring Harb Symp Quant Biol; 2006; 71():225-9. PubMed ID: 17381301
[TBL] [Abstract][Full Text] [Related]
13. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
[TBL] [Abstract][Full Text] [Related]
14. High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E-deficient mice.
Ketonen J; Merasto S; Paakkari I; Mervaala EM
Blood Press; 2005; 14(6):373-82. PubMed ID: 16403692
[TBL] [Abstract][Full Text] [Related]
15. Atheroma development in apolipoprotein E-null mice is not regulated by phosphorylation of p27(Kip1) on threonine 187.
Sanz-González SM; Melero-Fernández de Mera R; Malek NP; Andrés V
J Cell Biochem; 2006 Mar; 97(4):735-43. PubMed ID: 16229012
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
18. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres.
Herrera E; Samper E; Martín-Caballero J; Flores JM; Lee HW; Blasco MA
EMBO J; 1999 Jun; 18(11):2950-60. PubMed ID: 10357808
[TBL] [Abstract][Full Text] [Related]
19. Aging, telomeres, and atherosclerosis.
Edo MD; Andrés V
Cardiovasc Res; 2005 May; 66(2):213-21. PubMed ID: 15820190
[TBL] [Abstract][Full Text] [Related]
20. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ
J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
